V I TECHNOLOGIES INC
10-Q, EX-27.1, 2000-08-15
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: V I TECHNOLOGIES INC, 10-Q, EX-10.1, 2000-08-15
Next: NEW ZMAX CORP, 10-Q, 2000-08-15



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-30-2000
<PERIOD-START>                             JAN-02-2000
<PERIOD-END>                               JUL-01-2000
<CASH>                                          11,986
<SECURITIES>                                         0
<RECEIVABLES>                                    7,777
<ALLOWANCES>                                         0
<INVENTORY>                                      3,289
<CURRENT-ASSETS>                                23,900
<PP&E>                                          54,784
<DEPRECIATION>                                  14,762
<TOTAL-ASSETS>                                  68,530
<CURRENT-LIABILITIES>                           11,760
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           199
<OTHER-SE>                                      50,392
<TOTAL-LIABILITY-AND-EQUITY>                    68,530
<SALES>                                          7,875
<TOTAL-REVENUES>                                 8,541
<CGS>                                            7,263
<TOTAL-COSTS>                                   13,635
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                (23)
<INCOME-PRETAX>                                (4,715)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (4,715)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (4,715)
<EPS-BASIC>                                     (0.24)
<EPS-DILUTED>                                   (0.24)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission